Ftse Mib
34.196,34
-0,47%
DAX
19.137,05
-0,55%
S&P 500
5.949,17
-0,60%
NASDAQ
19.107,65
-0,64%
Bitcoin
87.697,09
0,40%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bicycle Therapeutics PLC (BCYC) Bicycle Therapeutics PLC (BCYC) Notizie

Bicycle Therapeutics PLC

BCYC
22,58
0,00 (0,00%)
15 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202422:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202415:00EDGAR2Form 144 - Report of proposed sale of securities
12/11/202413:00BWBicycle Therapeutics to Participate in the Jefferies London..
01/11/202421:05BWBicycle Therapeutics Reports Inducement Grants Under Nasdaq..
31/10/202412:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202412:05EDGAR2Form 8-K - Current report
31/10/202412:00BWBicycle Therapeutics Reports Recent Business Progress and..
23/10/202415:01EDGAR2Form 8-K - Current report
23/10/202413:00BWBicycle Therapeutics Announces First Human Imaging Data from..
16/10/202413:00BWBicycle Therapeutics to Present Radiopharmaceuticals Data at..
04/10/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202422:30EDGAR2Form 144 - Report of proposed sale of securities
03/10/202422:28EDGAR2Form 144 - Report of proposed sale of securities
03/10/202422:25EDGAR2Form 144 - Report of proposed sale of securities
03/10/202422:22EDGAR2Form 144 - Report of proposed sale of securities
03/10/202422:19EDGAR2Form 144 - Report of proposed sale of securities
03/10/202422:17EDGAR2Form 144 - Report of proposed sale of securities
03/10/202422:15EDGAR2Form 144 - Report of proposed sale of securities
02/10/202422:05BWBicycle Therapeutics Reports Inducement Grants Under Nasdaq..
19/9/202414:00EDGAR2Form 8-K - Current report
14/9/202409:00BWBicycle Therapeutics Presents Updated Clinical Results..
03/9/202422:05BWBicycle Therapeutics Reports Inducement Grants Under Nasdaq..
21/8/202413:00BWBicycle Therapeutics to Participate in Upcoming Investor..
06/8/202423:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/8/202413:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202413:05EDGAR2Form 8-K - Current report
06/8/202413:05BWBicycle Therapeutics Reports Recent Business Progress and..
01/8/202422:05BWBicycle Therapeutics Reports Inducement Grants Under Nasdaq..
22/7/202413:00BWBicycle Therapeutics Announces Four Abstracts Accepted for..
10/7/202422:50EDGAR2Form 8-K - Current report
09/7/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:18EDGAR2Form 8-K - Current report
18/6/202422:14EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
03/6/202413:00BWBicycle Therapeutics to Participate in Upcoming Investor..
23/5/202423:05BWBicycle Therapeutics to Present Pharmacokinetic and Safety..
23/5/202422:26EDGAR2Form 8-K - Current report
23/5/202413:00BWBicycle Therapeutics Announces $555 Million Private..
16/5/202422:01EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 22,58

La tua Cronologia

NASDAQ
BCYC
Bicycle Therapeutics
NASDAQ
ZEUS
Olympic Steel
AQEU
DES2D
Legal & General UCITS ETF
NYSE
KWR
Quaker Houghton
AMEX
KNW
Know Labs
NYSE
ALE
Allete
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network